The Latest
-
Insulet posts clinical data on fully closed-loop insulin delivery system
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
-
Vitestro raises $70M to ready blood collection robot for US launch
The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.
-
Medtronic elevates Sean Haag to president of ENT
Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.
-
Coloplast names former J&J executive Gavin Wood as CEO
Wood spent 20 years at J&J, culminating in a spell as company group chairman for the medtech business in Europe, the Middle East and Africa.
-
Medtronic to acquire Scientia Vascular for $550M
The Scientia deal follows Medtronic’s announcement in February that it’ll acquire CathWorks for up to $585 million.
-
SS Innovations raises $18.6M as surgical robot nears US market
Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.
-
ARPA-H launches program to develop biosensors that can track multiple signals
The research initiative is part of a broader focus on wearables at the Department of Health and Human Services.
-
Agilent to buy Biocare Medical for $950M
Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.
-
Medtronic’s MiniMed goes public for $560M
The diabetes tech business is now operating as a standalone, public company. Shares began trading on Friday.
-
Science Corporation raises $230M for Prima vision restoration device
The startup is seeking regulatory approval in Europe and the U.S. for the device, which restored vision to patients with late-stage macular degeneration in a small clinical trial.
-
Zimmer Biomet shares smart knee data at AAOS
The orthopedic firm published data showing patients with its Persona IQ implant had lower revision and physical therapy rates than those who received traditional knee implants.
-
Cognito raises $105M to bring Alzheimer’s treatment device to market
Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device designed to treat brain diseases using light and sound.
-
Profile
Inside CMR Surgical’s big pivot before US robot launch
CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.